Overview

Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss After Total Hip Replacement

Status:
Completed
Trial end date:
2021-04-26
Target enrollment:
Participant gender:
Summary
This study compares two oral medications (tranexamic acid and aminocaproic acid) as hemostatic agent administered in patients undergoing primary total hip replacement
Phase:
Phase 2
Details
Lead Sponsor:
Carlos A Acosta-Olivo
Treatments:
Aminocaproic Acid
Tranexamic Acid